4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0000947871-21-000360
Director sold 32,940 shares at an average $26.21 ($863,339)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC Director | 2021-03-19 | Sale | −21,275 | $26.47 | $563,149 | 2,439,958 | I |
| ORBIMED ADVISORS LLC Director | 2021-03-22 | Sale | −7,673 | $26.47 | $203,104 | 2,432,285 | I |
| ORBIMED ADVISORS LLC Director | 2021-03-23 | Sale | −3,992 | $24.32 | $97,085 | 2,428,293 | I |
| Open-market sales · 32,940 sh · avg $26.21 · $863,339 | |||||||
Loading xslF345X03/ownership.xml…